Inactivation of thrombomodulin by ionizing radiation in a cell-free system: Possible implications for radiation responses in vascular endothelium

Radiation Research

Volumn 169, Issue 4, 2008, Pages 408-416

  Ross, Christopher C ^a   MacLeod, Stewart L ^a   Plaxco, Jason R ^a   Froude, Jeffrey W ^b   Fink, Louis M ^c   Wang, Junru ^a   Stitesc, Wesley E ^b   Hauer Jensen, Martin ^a,d  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS   (United States)

^c NEVADA CANCER INSTITUTE   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; METHIONINE; MYELOPEROXIDASE; PROTEIN C; THROMBOMODULIN;

ARTICLE; CELL FREE SYSTEM; ENZYME INACTIVATION; GAMMA RADIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IONIZING RADIATION; MASS SPECTROMETRY; OXIDATION; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION RESPONSE; SURFACE PLASMON RESONANCE; VASCULAR ENDOTHELIUM;

CELL-FREE SYSTEM; ENDOTHELIUM, VASCULAR; HUMANS; METHIONINE; OXIDATION-REDUCTION; PROTEIN C; THROMBOMODULIN;

EID: 42949165607     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1148.1     Document Type: Article

References (41)

1. C. T. Esmon, New mechanisms for vascular control of inflammation mediated by natural anticoagulant proteins. J. Exp. Med. 196, 561-564 (2002).
2. K. K. Richter, L. M. Fink, B. M. Hughes, C-C. Sung and M. Hauer-Jensen, Is the loss of endothelial thrombomodulin involved in the mechanism of chronicity in late radiation enteropathy? Radiother. Oncol. 44, 65-71 (1997).
3. J. Wang, H. Zheng, X. Ou, L. M. Fink and M. Hauer-Jensen, Deficiency of microvascular thrombomodulin and upregulation of protease-activated receptor 1 in irradiated rat intestine: possible link between endothelial dysfunction and chronic radiation fibrosis. Am. J. Pathol. 160, 2063-2072 (2002).
4. M. Hauer-Jensen, L. M. Fink and J. Wang, Radiation injury and the protein C pathway. Crit. Care Med. 32, S325-S330 (2004).
5. J. Wang, M. Boerma, Q. Fu and M. Hauer-Jensen, Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy. World J. Gastroenterol. 13, 3047-3055 (2007).
6. P. P. Nawroth, D. A. Handley, C. T. Esmon and D. M. Stern, Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc. Natl. Acad. Sci. USA 83, 3460-3464 (1986).
7. E. M. Conway and R. D. Rosenberg, Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol. Cell Biol. 8, 5588-5592 (1988).
8. S. R. Lentz, M. Tsiang and J. E. Sadler, Regulation of thrombomodulin by tumor necrosis factor-α: comparison of transcriptional and posttranscriptional mechanisms. Blood 77, 542-550 (1991).
9. T. Ohji, H. Urano, A. Shirahata, M. Yamagishi, K. Higashi, S. Gotoh and Y. Karasaki, Transforming growth factor β1 and β2 induce down-modulation of thrombomodulin in human umbilical vein endothelial cells. Thromb. Haemost. 73, 812-818 (1995).
10. R. H. Sohn, C. B. Deming, D. C. Johns, H. C. Champion, C. Bian, K. Gardner and J. J. Rade, Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B. Blood 105, 3910-3917 (2005).
11. H. Ishii, H. Uchiyama and M. Kazama, Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb. Haemost. 65, 618-623 (1991).
12. M. W. J. Boehme, Y. Deng, U. Raeth, A. Bierhaus, R. Ziegler, W. Stremmel and P. P. Nawroth, Release of thrombomodulin from endothelial cells by concerted action of TNF-α and neutrophils: in vivo and in vitro studies. Immunology 87, 134-140 (1996).
13. Q. Zhou, Y. Zhao, C. Xu, Z. Yu, D. Yao, Y. Gao and C. Ruan, Increase in plasma thrombomodulin and decrease in plasma von Willebrand factor after regular radiotherapy of patients with cancer. Thromb. Res. 68, 109-118 (1992).
14. M. Hauer-Jensen, F-M. Kong, L. M. Fink and M. S. Anscher, Circulating thrombomodulin during radiation therapy of lung cancer. Radiat. Oncol. Invest. 7, 238-242 (1999).
15. C. B. Glaser, J. Morser, J. H. Clarke, E. Blasko, K. McLean, I. Kuhn, R. J. Chang, J. H. Lin, L. Vilander and W. H. Andrews, Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. J. Clin. Invest. 90, 2565-2573 (1992).
16. A. Kishida, M. Nakashima, N. Sakamoto, T. Serizawa, I. Maruyama and M. Akashi, Study on the complex formation between recombinant human thrombomodulin fragment and thrombin using surface plasmon resonance. Am. J. Hematol. 63, 136-140 (2000).
17. M. J. Wood and E. A. Komives, Production of large quantities of isotopically labeled protein in Pichia pastoris by fermentation. J. Biomol. NMR 13, 149-159 (1999).
18. C. N. Pace, F. Vajdos, L. Fee, G. Grimsley and T. Gray, How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 4, 2411-2423 (1995).
19. K. L. Moore, S. P. Andreoli, N. L. Esmon, C. T. Esmon and N. U. Bang, Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J. Clin. Invest. 79, 124-130 (1987).
20. I. R. MacGregor, A. M. Perrie, S. C. Donnelly and C. Haslett, Modulation of human endothelial thrombomodulin by neutrophils and their release products. Am. J. Respir. Crit. Care Med. 155, 47-52 (1997).
21. J. H. Clarke, D. R. Light, E. Blasko, J. F. Parkinson, M. Nagashima, K. McLean, L. Vilander, W. H. Andrews, J. Morser and C. B. Glaser, The short loop between epidermal growth factor-like domains 4 and 5 is critical for human thrombomodulin function. J. Biol. Chem. 268, 6309-6315 (1993).
22. 2+. Eur. J. Biochem. 262, 522-533 (1999).
23. M. J. Wood, A. Becvar, J. H. Prieto, G. Melacini and E. A. Komives, NMR structures reveal how oxidation inactivates thrombomodulin. Biochemistry 42, 11932-11942 (2003).
24. S. Vougier, J. Mary and B. Friguet, Subcellular localization of methionine sulphoxide reductase A (MsrA): evidence for mitochondrial and cytosolic isoforms in rat liver cells. Biochem. J. 373, 531-537 (2003).
25. J. Wang, H. Zheng, C-C. Sung and M. Hauer-Jensen, The synthetic somatostatin analogue, octreotide, ameliorates acute and delayed intestinal radiation injury. Int. J. Radiat. Oncol. Biol. Phys. 45, 1289-1296 (1999).
26. N. Hovdenak, L. F. Fajardo and M. Hauer-Jensen, Acute radiation proctitis: a sequential clinicopathologic study during pelvic radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 48, 1111-1117 (2000).
27. M. Albu, I. Barnes and R. Mocanu, Kinetic study of the temperature dependence of the OH initiated oxidation of dimethyl sulphide. In Environmental Simulation Chambers: Application to Atmospheric Chemical Processes (I. Barnes and K. J. Rudzinsky, Eds.), pp. 223-230. Springer Netherlands, Dordrecht, 2006.
28. M. B. Williams, P. Campuzano-Jost, A. J. Pounds and A. J. Hynes, Experimental and theoretical studies of the reaction of the OH radical with alkyl sulfides: 2. Kinetics and mechanism of the OH initiated oxidation of methylethyl and diethyl sulfides; observations of a two channel oxidation mechanism. Phys. Chem. Chem. Phys. 9, 4370-4382 (2007).
29. W. A. Dittman, T. Kumada, J. E. Sadler and P. W. Majerus, The structure and function of mouse thrombomodulin. Phorbol myristate acetate stimulates degradation and synthesis of thrombomodulin without affecting mRNA levels in hemangioma cells. J. Biol. Chem. 263, 15815-15822 (1988).
30. A. K. Ohlin and R. A. Marlar, The first mutation identified in the thrombomodulin gene in a 45-year-old man presenting with thromboembolic disease. Blood 85, 330-336 (1995).
31. T. Nakabayashi, K. Mizukami, S. Naitoh, M. Takeda, Y. Shikamoto, T. Nakagawa, H. Kaneko, T. Tarumi, I. Mizoguchi and T. Koike, Protein C Sapporo (protein C Glu 25 → Lys): a heterozygous missense mutation in the Gla domain provides new insight into the interaction between protein C and endothelial protein C receptor. Thromb. Haemost. 94, 942-950 (2005).
32. A. Marchiori, L. Mosena, M. H. Prins and P. Prandoni, The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies. Haematologica 92, 1107-1114 (2007).
33. E. Camerer, Unchecked thrombin is bad news for troubled arteries. J. Clin. Invest. 117, 1486-1489 (2007).
34. A. Baerga-Ortiz, A. R. Rezaie and E. A. Komives, Electrostatic dependence of the thrombin-thrombomodulin interaction. J. Mol. Biol. 296, 651-658 (2000).
35. J. Ye, C. T. Esmon and A. E. Johnson, The chondroitin sulfate moiety of thrombomodulin binds a second molecule of thrombin. J. Biol. Chem. 268, 2373-2379 (1993).
36. E. R. Stadtman, J. Moskovitz and R. L. Levine, Oxidation of methionine residues of proteins: biological consequences. Antioxid. Redox. Signal. 5, 577-582 (2003).
37. M. H. Barcellos-Hoff and T. A. Dix, Redox-mediated activation of latent transforming growth factor-β. Mol. Endocrinol. 10, 1077-1083 (1996).
38. M. F. Jobling, J. D. Mott, M. T. Finnegan, V. Jurukovski, A. C. Erickson, P. J. Walian, S. E. Taylor, S. Ledbetter, C. M. Lawrence and M. H. Barcellos-Hoff, Isoform-specific activation of latent transforming growth factor β (LTGF-β) by reactive oxygen species. Radiat. Res. 166, 839-848 (2006).
39. C. Taggart, D. Cervantes-Laurean, G. Kim, N. G. McElvaney, N. Wehr, J. Moss and R. L. Levine, Oxidation of either methionine 351 or methionine 358 in alpha-1-antitrypsin causes loss of anti-neutrophil elastase activity. J. Biol. Chem. 275, 27258-27265 (2000).
40. H. Carp, F. Miller, J. R. Hoidal and A. Janoff, Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. Proc. Natl. Acad. Sci. USA 79, 2041-2045 (1982).
41. P. J. Eifel, A. Jhingran, D. C. Badurka, C. Levenback and H. D. Thames, Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J. Clin. Oncol. 20, 3651-3657 (2002).